Exchange Traded Concepts LLC Buys 47,625 Shares of Semler Scientific, Inc. (NASDAQ:SMLR)

Exchange Traded Concepts LLC increased its position in Semler Scientific, Inc. (NASDAQ:SMLR) by 345.8% during the 4th quarter, Holdings Channel reports. The firm owned 61,396 shares of the company’s stock after acquiring an additional 47,625 shares during the quarter. Exchange Traded Concepts LLC’s holdings in Semler Scientific were worth $3,315,000 at the end of the most recent quarter.

Several other institutional investors also recently bought and sold shares of the company. State Street Corp raised its holdings in shares of Semler Scientific by 0.6% in the 3rd quarter. State Street Corp now owns 118,223 shares of the company’s stock valued at $2,784,000 after purchasing an additional 725 shares in the last quarter. Quest Partners LLC increased its holdings in Semler Scientific by 48.0% during the third quarter. Quest Partners LLC now owns 2,520 shares of the company’s stock valued at $59,000 after buying an additional 817 shares during the period. Newbridge Financial Services Group Inc. purchased a new position in Semler Scientific during the second quarter valued at approximately $34,000. US Bancorp DE raised its stake in Semler Scientific by 60.8% in the third quarter. US Bancorp DE now owns 3,064 shares of the company’s stock worth $72,000 after buying an additional 1,158 shares in the last quarter. Finally, Rhumbline Advisers lifted its holdings in Semler Scientific by 27.1% during the second quarter. Rhumbline Advisers now owns 6,197 shares of the company’s stock worth $213,000 after buying an additional 1,320 shares during the period. 49.37% of the stock is currently owned by hedge funds and other institutional investors.

Semler Scientific Stock Performance

SMLR stock opened at $55.46 on Friday. Semler Scientific, Inc. has a one year low of $20.88 and a one year high of $81.56. The firm has a market cap of $513.95 million, a price-to-earnings ratio of 27.05 and a beta of 1.18. The firm has a 50-day simple moving average of $60.44 and a two-hundred day simple moving average of $40.35.

Semler Scientific (NASDAQ:SMLR) last posted its quarterly earnings data on Monday, November 4th. The company reported $0.72 earnings per share for the quarter, topping analysts’ consensus estimates of $0.37 by $0.35. The firm had revenue of $13.51 million during the quarter. Semler Scientific had a return on equity of 20.31% and a net margin of 27.00%.

Wall Street Analysts Forecast Growth

Separately, Lake Street Capital lifted their price target on Semler Scientific from $40.00 to $71.00 and gave the company a “buy” rating in a report on Friday.

Semler Scientific Profile

Semler Scientific, Inc provides technology solutions to enhance the clinical effectiveness and efficiency of healthcare providers in the United States. The company’s products include QuantaFlo, a four-minute in-office blood flow test that enables healthcare providers to use blood flow measurements as part of their examinations of a patient’s vascular condition.